Fangping Chen
Central South University
5 Papers
18 Citations
Fangping Chen is an academic researcher from Central South University. The author has contributed to research in topics: Lenalidomide & CD34. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.
Xiao-Jun Huang,Feng-Rong Wang,Yu-Hong Chen,Ting Liu,Jianxiang Wang,Jianda Hu,Jin Jie,Fangping Chen,Shujie Wang,Shen Zx,Li Yu,Kang Yu,Yingmin Liang +12 more
TL;DR: The results of this trial indicate that posaconazole can be used in invasive fungal infections as an alternative or salvage therapy.
16
Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program
Xin Du,Jie Jin,Zhen Cai,Fangping Chen,Daobin Zhou,Li Yu,Xiaoyan Ke,Xiao Li,Depei Wu,Fanyi Meng,D. DeMarco,Jingshan Zhang,Jay Mei,Jian Hou +13 more
TL;DR: Long-term treatment with Rd has a predictable and manageable safety profile and provides sustained efficacy in Chinese patients with RRMM.
Role of glycosylphosphatidylinositol-specific phospholipase D in the homing of umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cells.
TL;DR: The results suggested that GPI-PLD probably had no contribution to HS/PC homing, which may due to its low or no expression in UCB, BM and MPB CD34(+) cells.
2
Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment
Dao bin Zhou,Li Yu,Xin Du,Jie Jin,Zhen Cai,Fangping Chen,Xiaoyan Ke,Xiao Li,Depei Wu,Fanyi Meng,Hui-Sheng Ai,Jingshan Zhang,D. DeMarco,Nianhang Chen,Jay Mei,Jianmin Wang,Jian Hou +16 more
TL;DR: In Chinese patients with advanced RRMM and RI, adjusting the starting dose of LEN according to renal function did not compromise the efficacy or safety of L EN+LoDEX.
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.
Yue-Yun Lai,Xiao-Jun Huang,Juan Li,Ping Zou,Zefeng Xu,Hui Sun,Zong-Hong Shao,Daobin Zhou,Fangping Chen,Zhuogang Liu,Huanling Zhu,Depei Wu,Chun Wang,Yin Zhang,Yan Li,Ming Hou,Xin Du,Xin Wang,Wei Li,Yongrong Lai,Jin Zhou,Yu-hong Zhou,Mei-Yun Fang,Lin Qiu,Xiaomin Wang,Guang-sen Zhang,Ming Jiang,Yingmin Liang,Lian-Sheng Zhang,Xie-Qun Chen,Hai Bai,Jin-Ying Lin +31 more
TL;DR: The multicenter studies emphasised and confirmed the importance of applying standardized FISH testing based on an appropriate panel of probes to detect common cytogenetic abnormalities in Chinese de novo MDS patients, particularly those with normal or failed CC results.